SUMMARY
- Neuralink Telepathy is a brain implant that lets people with paralysis control computers and phones using neural signals, currently only inside clinical trials.
- The name isn’t new (2024), but the data is: Neuralink reported 21 participants in January and an 11.32 bits-per-second cursor record on October 1.
- Indian founders can’t buy it, but should watch it: one Neuralink round matched over 40% of India’s 2025 deeptech funding, per Tracxn.
On October 30, Elon Musk posted a line he has been repeating for almost three years: Neuralink’s first product is called Telepathy. A few outlets covered it like a fresh unveiling. It isn’t.
Musk first named the product in January 2024, right after the first human implant. What’s new this week is the timing. Neuralink had just shared a video of its engineers spending 72 hours with a speech study participant, building tools to make thought-based communication smoother. Musk added that output bandwidth “will vastly exceed the fastest human speech or typing in a few years.”
So what is Neuralink Telepathy, really? Here’s what it does today, who can use it, and what founders should take from it.
It’s a medical implant, not mind reading
Forget the sci-fi picture of two people trading thoughts. Telepathy is a brain-computer interface, or BCI, built for people who can’t use their hands.
The hardware is the N1 implant. It carries 1,024 electrodes spread across 64 flexible threads, and a surgical robot places those threads in the part of the brain that plans movement. When a person with paralysis imagines moving a hand, the electrodes pick up the signals. Software decodes them into actions: move the cursor, click, type.
The person’s intention is the mouse. No headset, no controller.
What it can do right now
The headline number landed on October 1. Neuralink said one participant moved a cursor at 11.32 bits per second, above the 8 to 10 that able-bodied people typically manage with a mouse. That’s Neuralink’s own record, so treat it as a company claim until independent data shows up.
Typing is improving too. Neuralink’s January update reported up to 40 words per minute from imagined finger movements for some participants. And its October pretraining update says average calibration has dropped to about 55 minutes a week, which means less time training the system and more time using it.
Speech is the newest push. During the hackathon, engineers built automatic detection of when a user intends to speak, so nobody has to press start and stop. They also connected Neuralink’s Bloom speech app to iPhone calls, so generated speech plays straight into the call. One prototype even let a user trigger a Grok agent by thinking “Hey Neuralink,” according to Drive Tesla.
Read More: Meta Quietly Launches Style Sketch, an AI App That Plans Your Outfits From Instagram Photos
Who can actually use it
Only people enrolled in clinical trials, mostly those with severe paralysis or ALS. Musk said back in 2024 that the first users would be people who had lost the use of their limbs.
Neuralink’s January 28, 2026 update reported 21 enrolled participants and no serious device-related adverse events. Independent trackers count 27 or more by October, but that figure isn’t official.
Trial approvals have been reported in the US, Canada, the UK and the UAE. We found no Indian trial site. And there’s no consumer version: the FDA would need to approve any consumer product. Neuralink has said it hopes to implant a healthy person by 2030, which is a goal, not a schedule.
A fair dose of skepticism
Musk has a habit of big language around Neuralink, a point TechRadar made when Telepathy was first named. And Neuralink isn’t alone. Paradromics, Synchron and Precision Neuroscience are all in the race, and Precision implanted its device in a human back in 2023.
Blindsight, the vision product, is a good example of the gap between words and approvals. Musk said on October 30 that it’s ready from an engineering standpoint and waiting on regulators. The FDA’s breakthrough designation from September 2024 speeds up review, but it isn’t approval.
Read More: A Voice AI That Laughs, Sighs and Interrupts: Meet Jack Dorsey’s Dessa AI Voice Model
Why Indian founders should care
Neuralink raised $650 million in a single round in 2025. According to Tracxn, Indian deeptech startups raised $1.47 billion in total that year. One cheque matches more than 40% of the national figure.
That gap isn’t a reason to skip BCI or medtech. It’s a reminder of the clock. Neuralink’s path is trial first, publish the numbers, then scale. Any Indian deeptech or medtech founder faces the same sequence: patient capital, clinical partners, and regulators who don’t move at startup speed.
For investors, the signal is data cadence: participants, bits per second, calibration time. Those numbers tell you more than a product name does. Next up, watch whether Blindsight gets its first human implant (Neuralink’s updates page listed none as of late October) and whether the speech tools reach more study participants.
What founders should take from this
- Neuralink Telepathy works today only in clinical trials, for people with paralysis or ALS. Treat Musk’s timelines as ambition, not a launch date.
- Track Neuralink’s own updates for hard numbers: participants, bits per second, calibration time. Those matter more than the product name.
- Indian deeptech founders face the same slow clock: patient capital, trial data, regulators. Plan runway for years, not quarters.
Do you think thought-controlled computing reaches everyday users before 2030? Tell us in the comments, and keep reading StartupIndiaX for more deeptech coverage that’s built for founders.
FAQs
What is Neuralink Telepathy?
Neuralink Telepathy is the company’s first product, a brain implant that lets people with paralysis control computers and phones using neural signals. It’s currently available only to participants in clinical trials, not to the public.
How does Neuralink Telepathy work?
A coin-sized N1 implant places 1,024 electrodes across 64 threads in the brain. When a user imagines movement, the electrodes record the signals and software translates them into actions like moving a cursor, clicking or typing.
Who can use Neuralink Telepathy right now?
Only enrolled trial participants, mainly people with spinal cord injuries or ALS. Neuralink reported 21 participants in January 2026, and independent trackers count 27 or more. There’s no consumer version, and the FDA would need to approve one.
Is Neuralink Telepathy new in 2026?
No. Musk named Telepathy in January 2024. The October 30, 2026 post repeated it alongside Neuralink’s 72-hour speech hackathon update. What’s new is the performance data, including the 11.32 bits-per-second cursor record reported on October 1.
Is Neuralink Telepathy available in India?
Reported trial approvals cover the US, Canada, the UK and the UAE, and we found no Indian trial site. Anyone interested should check Neuralink’s official trial pages and the Clinical Trials Registry of India for updates.